What are the major opportunities in the Lung Cancer Liquid Biopsy market? What are the strategies for the Lung Cancer Liquid Biopsy market?

For detailed insights on the major opportunities and strategies in the Lung Cancer Liquid Biopsy market, Read More

How does the Lung Cancer Liquid Biopsy market relate to the overall economy and other similar markets?

For detailed insights on Lung Cancer Liquid Biopsy's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Lung Cancer Liquid Biopsy market growth? SWOT analysis of the Lung Cancer Liquid Biopsy market.

For detailed insights on the key dynamics influencing the Lung Cancer Liquid Biopsy market growth and SWOT analysis of the Lung Cancer Liquid Biopsy industry, Read More

Lung Cancer Liquid Biopsy Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Lung Cancer Liquid Biopsy Market Report 2026

Name: Lung Cancer Liquid Biopsy Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product (Instruments, Consumables, Kits And Reagents, Software And Services), By Technology (Multi-Gene-Parallel Analysis (Ngs), Single-Gene Analysis (PCR Microarrays)), By Biomarker (Cell-Free Deoxyribonucleic Acid, Circulating Tumor Deoxyribonucleic Acid, Extracellular Vesicles, Circulating Tumor Cells, Other Biomarkers), By Clinical Application (Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring, Other Applications), By End User (Diagnostics And Imaging Centres, Hospitals, Academics And Research Centers, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Lung Cancer Liquid Biopsy Market Overview

• Lung Cancer Liquid Biopsy market size has reached to $1.12 billion in 2025

• Expected to grow to $2.42 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%

• Growth Driver: Surge In Lung Cancer Cases Fuels Growth Of Market Due To Demand For Early Detection And Personalized Treatment

• Market Trend: Technological Advancements In Blood-Based Lung Cancer Screening Drive Early Detection Efforts

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lung Cancer Liquid Biopsy Market?

Lung cancer liquid biopsy is a non-invasive technique that analyzes blood or other body fluids to detect tumor-derived genetic material or cells. It enables early diagnosis, genetic profiling, and monitoring of lung cancer by capturing cancer-specific biomarkers, offering an alternative to surgical tissue biopsies.

The various lung cancer liquid biopsy products include instruments, consumables kits and reagents, and software and services. Instruments refers to the hardware and analytical devices used to process and analyze liquid biopsy samples. The technology involves multi-gene parallel analysis, such as next-generation sequencing (NGS), and single-gene analysis methods, such as PCR and microarrays. The various biomarkers include cell-free DNA, circulating tumor DNA, extracellular vesicles, circulating tumor cells, and other related markers, used in applications such as therapy selection, treatment monitoring, early cancer screening, recurrence monitoring, and other uses. The various end-users consist of diagnostic and imaging centers, hospitals, academic and research institutions, as well as other user groups.

Lung Cancer Liquid Biopsy Market Global Report 2026 Market Report bar graph

What Is The Lung Cancer Liquid Biopsy Market Size and Share 2026?

The lung cancer liquid biopsy market size has grown rapidly in recent years. It will grow from $1.12 billion in 2025 to $1.31 billion in 2026 at a compound annual growth rate (CAGR) of 17.0%. The growth in the historic period can be attributed to increasing lung cancer incidence rates, limitations of tissue biopsy procedures, advancements in molecular diagnostics, availability of circulating biomarker technologies, growth of oncology research activities.

What Is The Lung Cancer Liquid Biopsy Market Growth Forecast?

The lung cancer liquid biopsy market size is expected to see rapid growth in the next few years. It will grow to $2.42 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to increasing demand for precision oncology solutions, expansion of liquid biopsy clinical applications, rising adoption of companion diagnostics, growing integration of ai-driven data analysis, increased focus on early cancer screening programs. Major trends in the forecast period include increasing adoption of non-invasive diagnostic techniques, rising use of ngs-based liquid biopsy tests, growing demand for early cancer detection, expansion of personalized oncology diagnostics, enhanced integration of bioinformatics platforms.

Book your 30 minutes free consultation with our research experts

Global Lung Cancer Liquid Biopsy Market Segmentation

1) By Product: Instruments, Consumables, Kits And Reagents, Software And Services

2) By Technology: Multi-Gene-Parallel Analysis (Ngs), Single-Gene Analysis (PCR Microarrays)

3) By Biomarker: Cell-Free Deoxyribonucleic Acid, Circulating Tumor Deoxyribonucleic Acid, Extracellular Vesicles, Circulating Tumor Cells, Other Biomarkers

4) By Clinical Application: Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring, Other Applications

5) By End User: Diagnostics And Imaging Centres, Hospitals, Academics And Research Centers, Other End Users

Subsegments:

1) By Instruments: PCR Instruments, Microarray Instruments, Next-Generation Sequencing (NGS) Instruments

2) By Consumables Kits And Reagents: Sample Collection Kits, Amplification Reagents, Sequencing Reagents

3) By Software And Services: Data Analysis Software, Cloud-Based Services, Bioinformatics Tools

What Is The Driver Of The Lung Cancer Liquid Biopsy Market?

The increasing incidence of lung cancer is expected to propel the growth of the lung cancer liquid biopsy market going forward. Lung cancer is a disease characterized by the uncontrolled growth of abnormal cells in the lungs, often caused by smoking and environmental exposures. Lung cancer is increasing mainly due to continued tobacco use, as smoking exposes lungs to carcinogens that trigger abnormal cell growth. Lung cancer liquid biopsy helps by detecting cancer-related genetic mutations and tumor DNA from a blood sample, enabling early diagnosis, treatment selection, and monitoring of disease progression or response to therapy. For instance, in January 2023, according to a report published by the American Cancer Society (ACS), a U.S.-based nonprofit organization, in 2023, it is estimated that 238,340 individuals, including 117,550 men and 120,790 women, will be diagnosed with lung cancer, and 127,070 people are expected to die from the disease. Therefore, the increasing incidence of lung cancer is driving the growth of the lung cancer liquid biopsy industry.

Key Players In The Global Lung Cancer Liquid Biopsy Market

Major companies operating in the lung cancer liquid biopsy market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Biocept Inc., Agilent Technologies Inc., Eurofins Scientific, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Guardant Health Inc., Exosome Diagnostics Inc., Menarini Silicon Biosystems S.p.A., Inivata Ltd, Lucence Diagnostics Pte Ltd, LungLife AI Inc., Biodesix Inc., Oncocyte Corporation

Global Lung Cancer Liquid Biopsy Market Trends and Insights

Major companies operating in the lung cancer liquid biopsy market are focusing on developing technological advancements, such as blood-based lung cancer screening tests, to enhance early detection capabilities, improve diagnostic accuracy, and enable non-invasive, real-time monitoring of tumor progression and treatment response. A blood-based lung cancer screening test is a non-invasive approach that analyzes biomarkers in the bloodstream to identify the presence of lung cancer at an early stage. For instance, in October 2023, DELFI Diagnostics Inc., a US-based biotechnology company, launched a FirstLook Lung, a blood-based liquid biopsy test designed to aid in early lung cancer detection. That leverages fragmentomics to detect early lung cancer with high sensitivity and a 99.8% negative predictive value, making it a convenient and accessible first step for at-risk individuals. Its purpose is to improve early detection, increase screening rates, and help direct further imaging resources to those most likely to benefit.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Lung Cancer Liquid Biopsy Market?

In February 2024, Veracyte Inc., a US-based molecular diagnostics company, acquired C2i Genomics Inc. for an undisclosed amount. With this acquisition, Veracyte aims to enhance its cancer diagnostics by adding advanced whole-genome MRD liquid biopsy capabilities for improved detection and monitoring across multiple cancer types. C2i Genomics Inc. is a US-based company specializing in cancer detection and monitoring that offers lung cancer biopsy tests.

Regional Outlook

North America was the largest region in the lung cancer liquid biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lung Cancer Liquid Biopsy Market?

The lung cancer liquid biopsy market consists of revenues earned by entities by providing services such as mutation detection and genomic profiling, treatment monitoring, and early diagnosis and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The lung cancer liquid biopsy market also includes sales of NGS-based assays, CTC detection devices and others. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lung Cancer Liquid Biopsy Market Report 2026?

The lung cancer liquid biopsy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lung cancer liquid biopsy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Lung Cancer Liquid Biopsy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.31 billion
Revenue Forecast In 2035	$2.42 billion
Growth Rate	CAGR of 17.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product, Technology, Biomarker, Clinical Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Biocept Inc., Agilent Technologies Inc., Eurofins Scientific, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Guardant Health Inc., Exosome Diagnostics Inc., Menarini Silicon Biosystems S.p.A., Inivata Ltd, Lucence Diagnostics Pte Ltd, LungLife AI Inc., Biodesix Inc., Oncocyte Corporation
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Lung Cancer Liquid Biopsy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Lung Cancer Liquid Biopsy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Lung Cancer Liquid Biopsy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Lung Cancer Liquid Biopsy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Non-Invasive Diagnostic Techniques

4.2.2 Rising Use Of Ngs-Based Liquid Biopsy Tests

4.2.3 Growing Demand For Early Cancer Detection

4.2.4 Expansion Of Personalized Oncology Diagnostics

4.2.5 Enhanced Integration Of Bioinformatics Platforms

5. Lung Cancer Liquid Biopsy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostics And Imaging Centres

5.3 Academics And Research Centres

5.4 Oncology Clinics

5.5 Reference Laboratories

6. Lung Cancer Liquid Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lung Cancer Liquid Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Lung Cancer Liquid Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Lung Cancer Liquid Biopsy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Lung Cancer Liquid Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Lung Cancer Liquid Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lung Cancer Liquid Biopsy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lung Cancer Liquid Biopsy Market Segmentation

9.1. Global Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Instruments, Consumables, Kits And Reagents, Software And Services

9.2. Global Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Multi-Gene-Parallel Analysis (Ngs), Single-Gene Analysis (PCR Microarrays)

9.3. Global Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cell-Free Deoxyribonucleic Acid, Circulating Tumor Deoxyribonucleic Acid, Extracellular Vesicles, Circulating Tumor Cells, Other Biomarkers

9.4. Global Lung Cancer Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring, Other Applications

9.5. Global Lung Cancer Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostics And Imaging Centres, Hospitals, Academics And Research Centers, Other End Users

9.6. Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

PCR Instruments, Microarray Instruments, Next-Generation Sequencing (NGS) Instruments

9.7. Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Consumables Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sample Collection Kits, Amplification Reagents, Sequencing Reagents

9.8. Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Data Analysis Software, Cloud-Based Services, Bioinformatics Tools

10. Lung Cancer Liquid Biopsy Market Regional And Country Analysis

10.1. Global Lung Cancer Liquid Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Lung Cancer Liquid Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lung Cancer Liquid Biopsy Market

11.1. Asia-Pacific Lung Cancer Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lung Cancer Liquid Biopsy Market

12.1. China Lung Cancer Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lung Cancer Liquid Biopsy Market

13.1. India Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lung Cancer Liquid Biopsy Market

14.1. Japan Lung Cancer Liquid Biopsy Market Overview

14.2. Japan Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lung Cancer Liquid Biopsy Market

15.1. Australia Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lung Cancer Liquid Biopsy Market

16.1. Indonesia Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lung Cancer Liquid Biopsy Market

17.1. South Korea Lung Cancer Liquid Biopsy Market Overview

17.2. South Korea Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lung Cancer Liquid Biopsy Market

18.1. Taiwan Lung Cancer Liquid Biopsy Market Overview

18.2. Taiwan Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lung Cancer Liquid Biopsy Market

19.1. South East Asia Lung Cancer Liquid Biopsy Market Overview

19.2. South East Asia Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lung Cancer Liquid Biopsy Market

20.1. Western Europe Lung Cancer Liquid Biopsy Market Overview

20.2. Western Europe Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lung Cancer Liquid Biopsy Market

21.1. UK Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lung Cancer Liquid Biopsy Market

22.1. Germany Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lung Cancer Liquid Biopsy Market

23.1. France Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lung Cancer Liquid Biopsy Market

24.1. Italy Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lung Cancer Liquid Biopsy Market

25.1. Spain Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lung Cancer Liquid Biopsy Market

26.1. Eastern Europe Lung Cancer Liquid Biopsy Market Overview

26.2. Eastern Europe Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lung Cancer Liquid Biopsy Market

27.1. Russia Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lung Cancer Liquid Biopsy Market

28.1. North America Lung Cancer Liquid Biopsy Market Overview

28.2. North America Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lung Cancer Liquid Biopsy Market

29.1. USA Lung Cancer Liquid Biopsy Market Overview

29.2. USA Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lung Cancer Liquid Biopsy Market

30.1. Canada Lung Cancer Liquid Biopsy Market Overview

30.2. Canada Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lung Cancer Liquid Biopsy Market

31.1. South America Lung Cancer Liquid Biopsy Market Overview

31.2. South America Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lung Cancer Liquid Biopsy Market

32.1. Brazil Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lung Cancer Liquid Biopsy Market

33.1. Middle East Lung Cancer Liquid Biopsy Market Overview

33.2. Middle East Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lung Cancer Liquid Biopsy Market

34.1. Africa Lung Cancer Liquid Biopsy Market Overview

34.2. Africa Lung Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Technology, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lung Cancer Liquid Biopsy Market Regulatory and Investment Landscape

36. Lung Cancer Liquid Biopsy Market Competitive Landscape And Company Profiles

36.1. Lung Cancer Liquid Biopsy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Lung Cancer Liquid Biopsy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Lung Cancer Liquid Biopsy Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Biocept Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis

37. Lung Cancer Liquid Biopsy Market Other Major And Innovative Companies

Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Guardant Health Inc., Exosome Diagnostics Inc., Menarini Silicon Biosystems S.p.A., Inivata Ltd, Lucence Diagnostics Pte Ltd, LungLife AI Inc., Biodesix Inc., Oncocyte Corporation

38. Global Lung Cancer Liquid Biopsy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lung Cancer Liquid Biopsy Market

40. Lung Cancer Liquid Biopsy Market High Potential Countries, Segments and Strategies

40.1 Lung Cancer Liquid Biopsy Market In 2030 - Countries Offering Most New Opportunities

40.2 Lung Cancer Liquid Biopsy Market In 2030 - Segments Offering Most New Opportunities

40.3 Lung Cancer Liquid Biopsy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Lung Cancer Liquid Biopsy Market, Overview Of Key Products - Product Examples

Table 2: Global Lung Cancer Liquid Biopsy Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Lung Cancer Liquid Biopsy Market, Supply Chain Analysis

Table 4: Global Lung Cancer Liquid Biopsy Market, Major Raw Material Providers

Table 5: Global Lung Cancer Liquid Biopsy Market, Major Resource Providers

Table 6: Global Lung Cancer Liquid Biopsy Market, Major Manufacturers (Suppliers)

Table 7: Global Lung Cancer Liquid Biopsy Market, Major Distributors And Channel Partners

Table 8: Global Lung Cancer Liquid Biopsy Market, Key Technologies & Future Trends

Table 9: Global Lung Cancer Liquid Biopsy Market, Major Trends

Table 10: Global Lung Cancer Liquid Biopsy Market, Major End Users

Table 11: Global Lung Cancer Liquid Biopsy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Lung Cancer Liquid Biopsy Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Lung Cancer Liquid Biopsy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Lung Cancer Liquid Biopsy Market - TAM, US$ Billion, 2025

Table 15: Global Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Lung Cancer Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Lung Cancer Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Consumables Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Lung Cancer Liquid Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Lung Cancer Liquid Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Lung Cancer Liquid Biopsy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Lung Cancer Liquid Biopsy Market - Company Scoring Matrix

Table 99: F. Hoffmann-La Roche Ltd Financial Performance

Table 100: Thermo Fisher Scientific Inc. Financial Performance

Table 101: Biocept Inc. Financial Performance

Table 102: Agilent Technologies Inc. Financial Performance

Table 103: Eurofins Scientific Financial Performance

Table 104: Global Lung Cancer Liquid Biopsy Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Lung Cancer Liquid Biopsy Market, Competitive Dashboard

Table 106: Global Lung Cancer Liquid Biopsy Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Lung Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 108: Global, Lung Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 109: Global, Lung Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Biomarker, 2025 – 2030

List Of Figures

Figure 1: Global Lung Cancer Liquid Biopsy Market, Overview Of Key Products - Product Examples

Figure 2: Global Lung Cancer Liquid Biopsy Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Lung Cancer Liquid Biopsy Market, Supply Chain Analysis

Figure 4: Global Lung Cancer Liquid Biopsy Market, Major Raw Material Providers

Figure 5: Global Lung Cancer Liquid Biopsy Market, Major Resource Providers

Figure 6: Global Lung Cancer Liquid Biopsy Market, Major Manufacturers (Suppliers)

Figure 7: Global Lung Cancer Liquid Biopsy Market, Major Distributors And Channel Partners

Figure 8: Global Lung Cancer Liquid Biopsy Market, Key Technologies & Future Trends

Figure 9: Global Lung Cancer Liquid Biopsy Market, Major Trends

Figure 10: Global Lung Cancer Liquid Biopsy Market, Major End Users

Figure 11: Global Lung Cancer Liquid Biopsy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Lung Cancer Liquid Biopsy Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Lung Cancer Liquid Biopsy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Lung Cancer Liquid Biopsy Market - TAM, US$ Billion, 2025

Figure 15: Global Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Lung Cancer Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Lung Cancer Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Consumables Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Lung Cancer Liquid Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Lung Cancer Liquid Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Lung Cancer Liquid Biopsy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Lung Cancer Liquid Biopsy Market - Company Scoring Matrix

Figure 99: F. Hoffmann-La Roche Ltd Financial Performance

Figure 100: Thermo Fisher Scientific Inc. Financial Performance

Figure 101: Biocept Inc. Financial Performance

Figure 102: Agilent Technologies Inc. Financial Performance

Figure 103: Eurofins Scientific Financial Performance

Figure 104: Global Lung Cancer Liquid Biopsy Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Lung Cancer Liquid Biopsy Market, Competitive Dashboard

Figure 106: Global Lung Cancer Liquid Biopsy Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Lung Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 108: Global, Lung Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 109: Global, Lung Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Biomarker, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Lung Cancer Diagnostic And Screening Market Report 2026 - Global Outlook – By Product (Instruments, Consumables And Accessories), By Test (Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests), By Cancer Type ...

Liquid Biopsy Market Report 2026 - Global Outlook – By Product (Assay Kits, Instruments, Services ), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By En...

Lung Cancer Drugs Market Report 2026 - Global Outlook – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cance...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Small Cell Lung Cancer Therapeutics Market Report 2026 - Global Outlook – By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate, Pembrolizumab), By Treatment Type (Chemotherapy, Targeted Therapy,...

Pulmonary Drug Delivery Devices Market Report 2026 - Global Outlook – By Product Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), By Application (Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disea...

Clinical Oncology Next Generation Sequencing Market Report 2026 - Global Outlook – By Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible...

Frequently Asked Questions

How big is the Lung Cancer Liquid Biopsy Market?

The Lung Cancer Liquid Biopsy market was valued at $1.12 billion in 2025, increased to $1.31 billion in 2026, and is projected to reach $2.42 billion by 2030.

What is the Lung Cancer Liquid Biopsy market growth?

The global Lung Cancer Liquid Biopsy market is expected to grow at a CAGR of 16.7% from 2026 to 2035 to reach $2.42 billion by 2035.

Who are the key players in Lung Cancer Liquid Biopsy market?

Some Key Players in the Lung Cancer Liquid Biopsy market Include, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Biocept Inc., Agilent Technologies Inc., Eurofins Scientific, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Guardant Health Inc., Exosome Diagnostics Inc., Menarini Silicon Biosystems S.p.A., Inivata Ltd, Lucence Diagnostics Pte Ltd, LungLife AI Inc., Biodesix Inc., Oncocyte Corporation .

What is the anticipated growth trend for the Lung Cancer Liquid Biopsy market?

Major trend in this market includes: Technological Advancements In Blood-Based Lung Cancer Screening Drive Early Detection Efforts. For further insights on this market. request a sample here

Which region has the most growth potential in the Lung Cancer Liquid Biopsy market?

North America was the largest region in the lung cancer liquid biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer liquid biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.